Trial intelligence / Profile preview

Saquinavir SGC Salvage Therapy in Indinavir-Experienced HIV

NCT00000892Phase 2Completed

Sponsor
National Institute of Allergy and Infectious Diseases
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of saquinavir, delavirdine, adefovir dipivoxil in human immunodeficiency virus infection (HIV), sponsored by National Institute of Allergy and Infectious Diseases. Status: completed.

02

Drugs

saquinavirdelavirdineadefovir dipivoxil
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on NCT00000892.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00000892.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call